ido-in-1

IDO-IN-1 是吲哚胺-2,3-双加氧酶抑制剂，IC50=59 nM。

IDO-IN-12 是吲哚胺 2,3-双加氧酶抑制剂。

IDO-IN-13 (GS-4361) 是 indoleamine 2,3-dioxygenase 1 抑制剂，EC50=17 nM。

IDO-IN-18 (Compound 00815) 作为一种IDO抑制剂，主要用于研究与免疫抑制相关的感染或癌症疾病。

IDO-IN-15 is an IDO1 inhibitor ( IC 50 < 0.51 nM).

IDO-IN-16 (compound 5) 是一种 IDO 抑制剂 (IC50: 36 nM)。

IDO-IN-11 is an indoleamine-2,3-dioxygenase (IDO) inhibitor with IC50s of 0.18 μM (Kinase) and 0.014 μM (Hela Cell).

IDO-IN-14 是一种 IDO 抑制剂 (IC50: 0.6928 nM)。

Palmatine (Burasaine) 是口服具有活力的、不可逆IDO-1抑制剂。它可以减轻结肠损伤，预防肠道菌群失调和调节色氨酸分解代谢，从而改善DSS (Dextran Sulphate Sodium Salt) 诱发的结肠炎。它有用于结肠炎的研究潜力。

(R)-IDO/TDO-IN-1 (化合物 25) 为一种具有优良药动学性质的吲哚胺-2,3-双加氧酶 (IDO) 抑制剂，在MC38异种移植模型中展现出抗肿瘤活性。该化合物还与抗PD-1单克隆抗体 (SHR-1210) 显示协同作用。

IDO antagonist-1 (compound 163), an IDO antagonist, effectively inhibits the growth of pancreatic adenocarcinoma cells in C57BL 6 mice [1].

IDO Tubulin-IN-2 (HT2) 是一种对TDO和微管蛋白 (tubulin)展现出高效抑制作用的化合物。该抑制剂对多种癌细胞系（包括U87、HepG2、A549、HCT-116和LO2）均表现出强抗肿瘤活性，其半抑制浓度（IC50）分别为0.43、0.036、0.041、0.095和1.04 μM，有效提升了抗肿瘤效果。

IDO1-IN-11 is an IDO1 inhibitor with an IC 50 value of 0.6 nM.

IDO TDO-IN-1 is an orally active dual indoleamine-2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) inhibitor (IC50s: 9.7 and 47 nM).

IDO-IN-5 is an indoleamine 2,3-dioxygenase (IDO) inhibitor (IC50: 1-10 μM).

(S)-IDO1-IN-5 is an active S-isomer of IDO1-IN-5. (S)-IDO1-IN-5 binds to IDOL(IC50 value less than 1.5 µΜ).

IDO1-IN-7, a potent and selective indoleamine-2,3-dioxygenase-1 (IDO1) inhibitor, exhibits high potency with an IC 50 of 6.1 nM in the cellular assay (SKOV3). Apart from its inhibitory properties, IDO1-IN-7 also demonstrates immunomodulatory effects, contributing to its potential applications in cancer research.

Acid secretion-IN-1, a polycyclic compound, is synthesized for its application as an IDO inhibitor in synthetic experiments.

(Rac)-IDO1-IN-5 is a racemate of IDO1-IN-5, a potent, selective, and brain-penetrating inhibitor of Indoleamine 2,3-Dioxygenase 1 (IDO1) activity. It specifically binds to apo-IDO1, which lacks heme, instead of mature heme-bound IDO1.

IDOi-Pt(IV) prodrug-1 (Compound 10) 是一种 IDOi-Pt(IV) 前药，能够抑制IDO表达和诱导细胞凋亡(apoptosis)。它还能降低线粒体膜电位，并抑制肿瘤细胞的迁移及侵袭。IDOi-Pt(IV) prodrug-1 通过诱导活性氧介导的内质网应激和损伤相关分子模式 (DAMPs) 的分泌，从而产生免疫原性细胞死亡 (ICD) 效应。与顺铂相比，它表现出相对高效和低毒的抗肿瘤活性。

Coptisine Sulfate 是一种从黄连中分离到的生物碱，是非竞争性的IDO 抑制剂，Ki=为 5.8 μM，IC50=6.3 μM。

eIF4E-IN-1 (WO2021003194A1, compound Y), is a highly effective inhibitor of eIF4E, a key protein involved in immunosuppression. By targeting immune checkpoint proteins such as PD-1, PD-L1, LAG3, TIM3, and IDO, eIF4E-IN-1 functions to disrupt immune suppression and promote immune release in specific diseases such as cancer and infectious diseases.

IDO-IN-4 is an indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor.

IDO1-IN-12 is a potent and orally available IDO1 inhibitor.